Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 259.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,553 shares of the biopharmaceutical company’s stock after acquiring an additional 13,392 shares during the period. Tower Research Capital LLC TRC’s holdings in Regeneron Pharmaceuticals […]

Related Keywords

,Sanfordc Bernstein ,Leonards Schleifer ,Andrewj Murphy ,Regeneron Pharmaceuticals Inc ,Fortitude Family Office ,Cantor Fitzgerald ,Bruceg Allen Investments ,News Ratings For Regeneron Pharmaceuticals Daily ,Nasdaq ,Regeneron Pharmaceuticals Price Performance ,Securities Exchange Commission ,Tower Research Capital ,Regeneron Pharmaceuticals ,Quarter For Regeneron Pharmaceuticals ,Annis Gardner Whiting Capital Advisors ,Criterion Capital Advisors ,Holdings Channel ,Free Report ,Research Capital ,Gardner Whiting Capital Advisors ,Family Office ,Capital Advisors ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,